Altitude Sickness

Search with Google Search with Bing
Information
Disease name
Altitude Sickness
Disease ID
Description
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
Genes Mutation Description Source Links
NCT ID Status Phase Summary Start date Completion date
NCT04913389 Active, not recruiting Phase 3 Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD June 1, 2021 December 31, 2023
NCT01465971 Completed Monitoring of the Cerebral Tissue Oxygenation and Perfusion in the Adapting Climber During Sleep in High Altitude May 2011 December 2011
NCT02024386 Completed Phase 4 Efficacy Study of Riociguat and Its Effects on Exercise Performance and Pulmonary Artery Pressure at High Altitude January 2014 December 2015
NCT04075565 Completed N/A The Psychophysiological Effect of Simulated and Terrestrial Altitude June 24, 2019 April 30, 2022
NCT01171794 Completed Phase 3 Prevention of Altitude Illness With Non-steroidal Anti-inflammatory Study (PAINS) July 2010 August 2010
NCT04751292 Completed HIGH Altitude CArdiovascular REsearch Latin America Population Study January 26, 2021 December 30, 2023
NCT02760121 Completed Phase 4 AZ, MZ, and the Pulmonary System Response to Hypoxia May 2016 August 2016
NCT04915365 Recruiting Phase 3 Effect of Acetazolamide on Right Heart Function at Rest in Lowlanders With COPD Traveling to High Altitude May 1, 2021 December 31, 2023
NCT02972411 Unknown status N/A Controlled Hyperventilation as Prophylaxis for Acute Mountain Sickness October 2016 May 2017
NCT02780908 Unknown status N/A Cardio-respiratory Responses During Hypoxic Exercise in Individuals Born Prematurely April 2016 December 2018
NCT02941510 Withdrawn Phase 3 Inhaled Budesonide for Altitude Illness Prevention March 6, 2017 March 6, 2017
MeSH unique ID (MeSH (Medical Subject Headings))
D000532